Synthesis and activity of tyropeptin A derivatives as potent and selective inhibitors of mammalian 20S proteasome

被引:21
作者
Momose, I
Umezawa, Y
Hirosawa, S
Iijima, M
Iinuma, H
Ikeda, D
机构
[1] Microbial Chem Res Ctr, Numazu Biomed Res Inst, Shizuoka 4100301, Japan
[2] Microbial Chem Res Ctr, Shinagawa Ku, Tokyo 1410021, Japan
[3] Microbial Chem Res Ctr, Hiyoshi Med Chem Res Inst, Nakahara Ku, Kawasaki, Kanagawa 2110035, Japan
关键词
proteasome inhibitor; tyropeptin A derivative;
D O I
10.1271/bbb.69.1733
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tyropeptin A, a potent proteasome inhibitor, was isolated from the culture broth of Kitasatospora sp. MK993-dF2. We synthesized the derivatives of tyropeptin A to enhance its inhibitory potency. Among the synthesized derivatives, the most potent compound, TP-104, exhibited a 20-fold inhibitory potency enhancement for chymotrypsin-like activity of 20S proteasome compared to tyropeptin A. Additionally, TP-110 specifically inhibited the chymotrypsin-like activity, but did not inhibit the post-glutamyl-peptide hydrolyzing (PGPH) and the trypsin-like activities of 20S proteasome. In vitro TP-110 strongly inhibited the growth of various cell lines.
引用
收藏
页码:1733 / 1742
页数:10
相关论文
共 13 条
[1]  
Adams J, 1999, CANCER RES, V59, P2615
[2]   Potent and selective inhibitors of the proteasome: Dipeptidyl boronic acids [J].
Adams, J ;
Behnke, M ;
Chen, SW ;
Cruickshank, AA ;
Dick, LR ;
Grenier, L ;
Klunder, JM ;
Ma, YT ;
Plamondon, L ;
Stein, RL .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (04) :333-338
[3]   DEGRADATION OF NUCLEAR ONCOPROTEINS BY THE UBIQUITIN SYSTEM INVITRO [J].
CIECHANOVER, A ;
DIGIUSEPPE, JA ;
BERCOVICH, B ;
ORIAN, A ;
RICHTER, JD ;
SCHWARTZ, AL ;
BRODEUR, GM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (01) :139-143
[4]   Structure and functions of the 20S and 26S proteasomes [J].
Coux, O ;
Tanaka, K ;
Goldberg, AL .
ANNUAL REVIEW OF BIOCHEMISTRY, 1996, 65 :801-847
[5]   Ubiquitination of p53 and p21 is differentially affected by ionizing and UV radiation [J].
Maki, CG ;
Howley, PM .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (01) :355-363
[6]   Structure-based design of derivatives of tyropeptin A as the potent and selective inhibitors of mammalian 20S proteasome [J].
Momose, I ;
Umezawa, Y ;
Hirosawa, S ;
Iinuma, H ;
Ikeda, D .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (07) :1867-1871
[7]   Inhibition of proteasome activity by tyropeptin A in PC12 cells [J].
Momose, I ;
Sekizawa, R ;
Iinuma, H ;
Takeuchi, T .
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 2002, 66 (10) :2256-2258
[8]   Tyropeptins A and B, new proteasome inhibitors produced by Kitasatospora sp MK993-dF2 -: II.: Structure determination and synthesis [J].
Momose, I ;
Sekizawa, R ;
Hirosawa, S ;
Ikeda, D ;
Naganawa, H ;
Iinuma, H ;
Takeuchi, T .
JOURNAL OF ANTIBIOTICS, 2001, 54 (12) :1004-1012
[9]   Tyropeptins A and B, new proteasome inhibitors produced by Kitasatospora sp MK993-dF2 -: I.: Taxonomy, isolation, physico-chemical properties and biological activities [J].
Momose, S ;
Sekizawa, R ;
Hashizume, H ;
Kinoshita, N ;
Homma, Y ;
Hamada, M ;
Iinuma, H ;
Takeuchi, T .
JOURNAL OF ANTIBIOTICS, 2001, 54 (12) :997-1003
[10]   ROLE OF THE UBIQUITIN-PROTEASOME PATHWAY IN REGULATING ABUNDANCE OF THE CYCLIN-DEPENDENT KINASE INHIBITOR P27 [J].
PAGANO, M ;
TAM, SW ;
THEODORAS, AM ;
BEERROMERO, P ;
DELSAL, G ;
CHAU, V ;
YEW, PR ;
DRAETTA, GF ;
ROLFE, M .
SCIENCE, 1995, 269 (5224) :682-685